Navigation Links
Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency
Date:1/24/2013


According to Mr. O’Donnell, “To develop a commercially viable cell therapy, companies have to consider packaging, storage, inventory management, monitoring systems, distribution, and even clinical site capabilities from the very beginning. Companies that overlook these issues until clinical trials begin can find that they have inadvertently limited their product’s scalability and commercial viability, or incurred unnecessary costs and complications downstream.”
Following his talk, Mr. O’Donnell will also participate in the round table discussion, “What does a commercially successful cell or gene therapy look like?”

The first breakout session following the plenary talks will address commercially feasible manufacturing and business models. Mr. Simpson, Fisher BioServices’ Director of Commercial Operations, will offer his insights on cold chain transport and building efficiency into operational processes, and will discuss recent case studies for allogeneic vs. autologous therapies. He will then participate in a roundtable discussion focused on minimizing the cost of goods and maximizing efficiency of operations.

About Fisher BioServices
Fisher BioServices has 25 years of experience in biological repository/biobanking services, cold chain logistics, and in supporting clinical trials and public health research. The company manages more than 170,000,000 high value biological specimens, cell-based therapeutics, vaccines, tissues, and sample-related data. Fisher BioServices has cGMP compliant repositories, laboratories, and specimen collection kit production and clinical trial support capabilities, depots, and affiliated sites around the world, and serves more than 20 government and hundreds of commercial clients. Fisher BioServices is part of Thermo Fisher Scientific, Inc., the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. The comp
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ORNL wins 9 R&D 100s, bringing total to 173
2. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
5. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
6. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
7. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
8. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
9. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
10. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
11. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... LANSING, Mich. , July 7, 2015  Neogen ... has signed an agreement to expand its relationship with ... sequencing and genomics. Under the agreement, Illumina will market ... on Illumina Infinium ® BeadArray technology, to the ... Illumina,s largest agrigenomic customers through its GeneSeek ® ...
(Date:7/7/2015)... , July 7, 2015   Moleculera ... two-year, $300,000 matching grant from the Oklahoma Center ... This grant supports the development and clinical validation ... directed against neuronal antigens in patients experiencing neuropsychiatric ... Such panels are intended to assist physicians in ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 ... RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into ...
(Date:7/7/2015)... ... ... CSM, a leading clinical trial supply company, today announced that Michael Morse ... background in financial management and accounting, bringing over 20 years of experience in the ... oversee all financial areas of the company to both strengthen CSM’s financial strategy and ...
Breaking Biology Technology:Neogen signs commercialization agreement with Illumina 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5CSM Appoints Michael Morse as Vice President of Finance 2
... Company Announces Revised Operating Plan to Respond to NEBIDO ... (Nasdaq: IDEV ) today announced that it has ... Administration (FDA) for,NEBIDO(R) related to a New Drug Application ... received on June 27, 2008, indicated that the,application may ...
... The Worldwide Center for Adult Stem,Cell Education ... has formally changed its name to The Repair ... based in Dallas,with offices in Washington, D.C. and ... medical treatment center locations around the world,so they ...
... SHANGHAI, China, June 30 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC ... the research, development, manufacture, marketing and,distribution of probiotics ... call at 9:00 a.m. EDT on Friday, July ... the fourth quarter and full,year ended March 31, ...
Cached Biology Technology:Indevus Receives Approvable Letter from FDA for NEBIDO(R) 2Indevus Receives Approvable Letter from FDA for NEBIDO(R) 3Indevus Receives Approvable Letter from FDA for NEBIDO(R) 4Indevus Receives Approvable Letter from FDA for NEBIDO(R) 5Indevus Receives Approvable Letter from FDA for NEBIDO(R) 6Indevus Receives Approvable Letter from FDA for NEBIDO(R) 7Worldwide Center for Adult Stem Cell Education LLC Changes Name to 'The Repair Stem Cell Institute LLC' 2China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results 2China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results 3
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... from the Wildlife Conservation Society and the University of St. ... tourism industry and a symbol of Africaare on the verge ... the results of a recent survey, African lions in Uganda ... 10 years in some areas of the country, mostly the ...
... strong growth of the bioeconomy, a pool of skilled ... areas of bioenergy and biobased products. A proven strategy ... and industry to work together to develop innovation solutions ... a Roundtable Discussion published in Industrial Biotechnology ...
... years, Patrick Cramer and his colleagues at Ludwig-Maximilians-Universitaet (LMU) ... I, a crucial cog in the machinery of all ... the enzyme at atomic resolution. Actively growing ... turn requires huge numbers of protein production plants, the ...
Cached Biology News:King of beasts losing ground in Uganda's paradise 2King of beasts losing ground in Uganda's paradise 3Training the future biomanufacturing workforce 2Molecular biology: Designer of protein factories exposed 2Molecular biology: Designer of protein factories exposed 3
... rocking platform, 120 V, is used for agitation ... liquid cultures, staining and destaining of gels and ... speed control (8-40 rpm) and can handle a ... rocker features two 29 x 21 cm platforms ...
... Acid) Clear to very pale yellow ... 2 O 2 in a citrate buffer ... is soluble, safe, convenient and has good overall ... blue-green color that can be measured at 405 ...
... Tube Disperser System from IKA Works is the ... cleaner, safer, and more efficient way to disperse ... 2 to 15 ml inside sealed tubes. Depending ... of 4 different tube types. Each tube is ...
... Triple-angle light scattering detector for ... digital signal processing hardware for two ... UV detectors. Also contains an analog ... interfacing to strip chart recorders. Includes ...
Biology Products: